TAF1 and X-linked dystonia-parkinsonism: Here, we sought to develop a bespoke precision therapy for XDP, leveraging our previous discoveries of a causal noncoding SVA in XDP and the expression hallmarks of aberrant splicing and dysregulation of TAF1 function.